Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus...
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
About this item
Full title
Author / Creator
Publisher
United States: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Lassa virus (LASV) is a World Health Organization (WHO) priority pathogen that causes high morbidity and mortality. Recently, we showed that a combination of three broadly neutralizing human monoclonal antibodies known as Arevirumab-3 (8.9F, 12.1F, 37.2D) based on the lineage IV Josiah strain protected 100% of cynomolgus macaques against heterologo...
Alternative Titles
Full title
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_055f26a5860147ff8cc66a9db9b3c6b4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_055f26a5860147ff8cc66a9db9b3c6b4
Other Identifiers
ISSN
2222-1751
E-ISSN
2222-1751
DOI
10.1080/22221751.2023.2301061
